Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare

ARWR Message Board | Arrowhead Pharmaceuticals Inc.

home / stock / arwr / arwr message board

ARWR ARWR Quote ARWR Short ARWR News ARWR Articles ARWR Message Board

Message Board | Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR)

Subject	By	Source	When
whytestocks: $ARWR News Article - Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday	whytestocks	investorshangout	04/25/2023 3:35:46 PM
$ARWR still ascending.	MiamiGent	investorshub	01/13/2023 4:36:57 PM
whytestocks: $ARWR News Article - Arrowhead Pharmaceuticals Announces $25 Million Milestone Payment	whytestocks	investorshangout	12/20/2022 4:25:49 PM
Arrowhead is an amazing company. Gene silencing	jimmy667	investorshub	10/22/2022 8:11:09 AM
whytestocks: $ARWR News Article - 5 Top Biotech Stocks To Watch In July 2022	whytestocks	investorshangout	06/30/2022 6:55:50 PM
whytestocks: $ARWR News Article - Arrowhead Pharmaceuticals to Participate in Upcoming June 2022 Con	whytestocks	investorshangout	06/07/2022 4:55:52 PM
whytestocks: $ARWR News Article - Arrowhead Files for Regulatory Clearance to Initiate Phase 1/2a St	whytestocks	investorshangout	03/24/2022 8:41:25 PM
whytestocks: $ARWR News Article - Arrowhead Initiates Project to Build New Manufacturing and Lab Fac	whytestocks	investorshangout	12/20/2021 8:45:48 PM
whytestocks: $ARWR News Article - 4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyo	whytestocks	investorshangout	11/23/2021 9:25:54 PM
whytestocks: $ARWR News Article - Arrowhead Pharmaceuticals Initiates Phase 2b Study of ARO-APOC3 fo	whytestocks	investorshangout	09/30/2021 6:30:51 PM
whytestocks: $ARWR News Article - Arrowhead Pharmaceuticals: Buy the Dip?	whytestocks	investorshangout	07/19/2021 4:35:50 PM
whytestocks: $ARWR News Article - Arrowhead Announces ARO-DUX4 as First Muscle Targeted RNAi Candida	whytestocks	investorshangout	04/15/2021 12:20:54 PM
whytestocks: $ARWR News Article - Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinars on C	whytestocks	investorshangout	11/04/2020 4:25:49 PM
NEWS: $ARWR Why Arrowhead Pharmaceuticals Stock Jumped Today	whytestocks	investorshub	10/15/2020 10:00:35 PM
znewcar1: ARWR 40% v23,9M c47.43 f102M H53.12 gap and go it was done before noon got S@47.2	znewcar1	investorshangout	09/16/2020 10:11:00 PM
* * $ARWR Video Chart 09-16-2020 * *	ClayTrader	investorshub	09/16/2020 9:05:16 PM
$ARWR $weet upside run....check out$ QRTEB > nice	crudeoil24	investorshub	09/16/2020 5:50:17 PM
great gapper this one today	$treet $inatra	investorshub	09/16/2020 4:08:08 PM
Arrowhead Pharmaceuticals shares are trading higher after the	crudeoil24	investorshub	09/16/2020 3:32:47 PM
$ARWR MOVING VERY SWIFTLY TOO FOR A STOCK	otcmoneydoubler	investorshub	09/16/2020 3:29:48 PM

Stock Information

Get ARWR Alerts

News, Short Squeeze, Breakout and More Instantly...

Arrowhead Pharmaceuticals Inc. Company Name:

ARWR Stock Symbol:

NASDAQ Market:

-0.93% G/L:

$15.36 Last:

979,542 Volume:

$15.21 Open:

$15.36 Close:

Arrowhead Pharmaceuticals Inc. Website:

Arrowhead Pharmaceuticals Inc. Logo

ARWR - Arrowhead Pharmaceuticals Announces Topline Results from Part 2 of Phase 1/2 Study of ARO-C3 in Patients with IgA Nephropathy

- ARO-C3 achieved deep and sustained reductions in alternative pathway complement activity and proteinuria - Mean sustained reductions in C3 of ≥87%, AH50 of ≥76%, Wieslab AP of ≥89% through week 24 - Mean reduction in spot urine protein-to-creatinine ratio (UPCR) of ...
ARWR - Arrowhead Pharmaceuticals Showcases Two Clinical-Stage RNAi-Based Candidates to Treat Obesity and Metabolic Diseases

- ARO-INHBE and ARO-ALK7 both target a known pathway that signals the body to store fat in adipose tissue with a novel mechanism of action that may better preserve lean muscle mass compared to currently approved obesity therapies - Data highlight Arrowhead’s leadership in the use of RN...
ARWR - Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (FCS)

New Patient Resource Hub: Arrowhead expands its We’ll Get There Soon campaign with the launch of a dedicated patient website, providing education, tools, and support for those living with FCS and extremely high triglycerides Amplifying Patient Voices: The Spotlight on FCS ...